Inventor
STAMM SIMON
SE13 patents
⚠️ This page may combine multiple inventors who share the name “STAMM SIMON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IDORSIA PHARMACEUTICALS LTD
6 patentsUS10246426B2Apr 2, 2019
Triazole compounds as T-type calcium channel blockers
IDORSIA PHARMACEUTICALS LTD5 citations71
US10065929B2Sep 4, 2018
Pyrazole compounds and their use as T-type calcium channel blockers
IDORSIA PHARMACEUTICALS LTD5 citations71
US9932314B2Apr 3, 2018
Pyrazole compounds and their use as T-type calcium channel blockers
IDORSIA PHARMACEUTICALS LTD5 citations71
US11739070B2Aug 29, 2023
C5A receptor modulators
IDORSIA PHARMACEUTICALS LTD0 citations48
US11685729B2Jun 27, 2023
C5a receptor modulators
IDORSIA PHARMACEUTICALS LTD0 citations48
US11608341B2Mar 21, 2023
Substituted tetrahydropyrazolo[3,4-d]pyrimidines and tetrahydropyrazolo[4,3-d]pyrimidines as C5A receptor modulators
IDORSIA PHARMACEUTICALS LTD0 citations48
ACTELION PHARMACEUTICALS LTD
4 patentsUS9388198B2Jul 12, 2016
Heterocyclic amide derivatives as P2X7 receptor antagonists
ACTELION PHARMACEUTICALS LTD0 citations51
US9718774B2Aug 1, 2017
Indole carboxamide derivatives as P2X7 receptor antagonist
ACTELION PHARMACEUTICALS LTD0 citations40
US9556117B2Jan 31, 2017
Indole carboxamide derivatives as P2X7 receptor antagonists
ACTELION PHARMACEUTICALS LTD0 citations40
US9388197B2Jul 12, 2016
Heterocyclic amide derivatives as P2X7 receptor antagonists
ACTELION PHARMACEUTICALS LTD0 citations40